Delivery Order SPE2DB22D3019-SPE2DB26FK2TX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Quviviq 25 mg tablets in a quantity of 30 units, with a ceiling value of $1,268.29. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Quviviq 50 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,705.59, with completion targeted for August 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.20 to AmerisourceBergen Drug Corp for the supply of Quviviq 25 mg tablets (30-count package) under a firm fixed-price contract type. This delivery order, issued on October 22, 2025, represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Quviviq 25 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,829.63. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,712.87 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quviviq 25 mg tablets (30-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.41 to AmerisourceBergen Drug Corp for 30 tablets of Quviviq 25 mg on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed price contract represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Quviviq is a prescription insomnia medication, reflecting the Department of Defense's ongoing pharmaceutical supply needs for...
- The Defense Logistics Agency awarded a delivery order valued at $1,283.67 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. QUVIVIQ is a prescription medication used in the treatment of insomnia, representing...
- The Defense Logistics Agency awarded a $3,846.82 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count) on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,274.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Quviviq 50 mg tablets (30-count). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,212.55 for Quiviviq 25 mg tablets (30-count packages) on September 25, 2025, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB26FK2TXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Quviviq 25 mg tablets in a quantity of 30s. This is a firm fixed price delivery order with a ceiling value of $1,662.22, representing a non-set-aside competitive award. The contract has an ultimate completion date of November 5, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, enabling flexible fulfillment of federal healthcare requirements. This delivery order for Quviviq, an insomnia medication, reflects the company's ongoing role in supplying specialty pharmaceuticals to support Defense Health Agency operations and other government healthcare systems through the global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/4/25 |